IMARC Group has recently released a new research study titled “United States Tumor Ablation Market Report by Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation), Mode of Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others), End User (Hospitals, Cancer Specialty Clinics, and Others), and Region 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
Market Overview
The United States tumor ablation market size was USD 323.3 Million in 2024 and is projected to reach USD 732.0 Million by 2033, growing at a CAGR of 9.5% during 2025-2033. Growth is driven by the increasing demand for minimally invasive techniques that reduce recovery time and complications. Tumor ablation methods such as radiofrequency, microwave, and cryoablation are increasingly preferred for treating cancers in the liver, lungs, kidneys, and bones.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
United States Tumor Ablation Market Key Takeaways
- Current Market Size: USD 323.3 Million in 2024
- CAGR: 9.5%
- Forecast Period: 2025-2033
- Tumor ablation is a minimally invasive medical procedure used to destroy tumors in organs like liver, kidney, lung, and bones.
- Common technologies include radiofrequency ablation, microwave ablation, and cryoablation.
- Growth is driven by technological advancements, rising cancer prevalence, an aging population, and personalized medicine initiatives.
- Market segmentation includes technology, mode of treatment, mode of application, end user, and region.
Sample Request Link: https://www.imarcgroup.com/united-states-tumor-ablation-market/requestsample
United States Tumor Ablation Market Growth Factors
Advancements in imaging technologies such as ultrasound, CT, and magnetic resonance imaging are key factors driving United States tumor ablation market growth, as they enable precise tumor localization while minimizing damage to surrounding healthy tissue. Growing preference among the healthcare professionals for minimally intrusive procedures over surgical interventions is also a factor contributing to the market growth.
The market is also increased by increased cancer incidences in the region. The need for efficient cancer therapies is constantly increasing. Tumor ablation can shorten hospital-stay and complication rates, and is therefore attractive to providers and patients as the incidence of cancers in the liver, lung, and kidney and metastases to bone, rises.
Demographics also play a role, as an aging population is more likely to have comorbidities making surgery a riskier option, making ablation an attractive alternative. The trend for personalized medicine has encouraged wide-ranging research and development, notably through collaboration between pharmaceutical companies and research institutes. The result of this has been the development of new ablation technologies, tailored specifically to the individual patient to improve outcomes.
To get more information on this market, Request Sample
United States Tumor Ablation Market Segmentation
Breakup By Technology:
- Radiofrequency (RF) Ablation: Uses high-frequency electrical currents to generate heat to destroy cancer cells.
- Microwave Ablation: Employs microwaves to heat and eliminate tumors.
- Cryoablation: Involves freezing the tumor to destroy cancerous tissue.
- Others
Breakup By Mode of Treatment:
- Percutaneous Ablation: Minimally invasive treatment administered through the skin using needles or probes.
- Laparoscopic Ablation: Uses small incisions and specialized instruments to treat tumors.
- Surgical Ablation: Traditional invasive surgical methods to remove or destroy tumors.
Breakup By Mode of Application:
- Liver Cancer: Ablation treatments targeted at cancerous tumors in the liver.
- Lung Cancer: Application of ablation techniques to treat lung tumors.
- Kidney Cancer: Ablation procedures aimed at kidney tumor destruction.
- Bone Metastasis: Treatment of tumors that have spread to the bones.
- Others
Breakup By End User:
- Hospitals: Primary healthcare facilities where ablation treatments are performed.
- Cancer Specialty Clinics: Specialized centers focused on oncology and tumor treatments.
- Others: Other healthcare providers or institutions using tumor ablation.
Regional Insights
The market report covers the major regions in the United States, including Northeast, Midwest, South, and West. Specific regional market share or CAGR data for these regions is not provided in the source. Therefore, identification of the dominant region based on exact statistics is not available. The report states comprehensive analysis for all these regions, implying all hold strategic importance.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=20659&flag=C
Competitive Landscape
The market research report covers a comprehensive competitive landscape analysis including market structure, key player positioning, winning strategies, competitive dashboards, and company evaluation quadrants. Detailed profiles of all major companies have been provided.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: [email protected],
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
